Table 2.
Measure | MDD | SCZ | HC | ||||||
---|---|---|---|---|---|---|---|---|---|
Occ | Soc | Symp | Occ | Soc | Symp | Occ | Soc | Symp | |
BACS | 0.22a | 0.12a | 0.001a | 0.41**a | 0.25a | 0.39**a | 0.14 | 0.17 | 0.08 |
NSA-16 | −0.19a | −0.19a | −0.39**a | −0.32*a | −0.36*a | −0.20a | 0.08 | −0.17 | −0.07 |
PHQ-9 | −0.07a | −0.54**a | −0.50**a | −0.18 | −0.11 | −0.32* | −0.10 | −0.21 | −0.15 |
p < 0.05,
p < 0.01.
Pearson's correlation.
BACS, Brief Assessment of Cognition in Schizophrenia; NSA-16, Negative Symptom Assessment; PHQ-9, Patient Health Questionnaire; Occ, MIRECC-GAF Occupational functioning; Soc, MIRECC-GAF Social functioning; Symp, MIRECC-GAF Symptomatic functioning.